Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_assertion type Assertion NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_head.
- NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_assertion description "[Thus, recombinant SP-D has been proposed as a therapeutical option for cystic fibrosis, neonatal lung disease and smoking-induced emphysema.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_provenance.
- NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_assertion evidence source_evidence_literature NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_provenance.
- NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_assertion SIO_000772 16684127 NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_provenance.
- NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_assertion wasDerivedFrom befree-20150227 NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_provenance.
- NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_assertion wasGeneratedBy ECO_0000203 NP691916.RAeUf2cQCrX7JIFbALCxdlx6KoAMlHNX8s_NUAjiPPk3o130_provenance.